Related references
Note: Only part of the references are listed.Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Charles J. Glueck et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Dorte Glintborg et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Regulation of plasminogen activation on cell surfaces and fibrin
T. Urano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
Hector F. Escobar-Morreale
NATURE REVIEWS ENDOCRINOLOGY (2018)
Increased Coagulation and Decreased Fibrinolysis as Measured with Overall Hemostatic Potential Are Dependent on BMI and Not Associated with PCOS
Matej Rakusa et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2017)
Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women
Johannes J. Sidelmann et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Inhibition of Fibrinolysis by Coagulation Factor XIII
Dingeman C. Rijken et al.
BIOMED RESEARCH INTERNATIONAL (2017)
New insights into the role of adipose tissue in thrombosis
Gemma Vilahur et al.
CARDIOVASCULAR RESEARCH (2017)
Factor XIII: Structure and Function
Verena Schroeder et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2016)
Evaluation of Fibrinolytic Inhibitors: Alpha-2-Antiplasmin and Plasminogen Activator Inhibitor 1 in Patients with Obstructive Sleep Apnoea
Maciej Zakrzewski et al.
PLOS ONE (2016)
Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes
Mubeena Aziz et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2015)
Increased thrombin generation in women with polycystic ovary syndrome A pilot study on the effect of metformin and oral contraceptives
Dorte Glintborg et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Body Composition Is Improved During 12 Months' Treatment With Metformin Alone or Combined With Oral Contraceptives Compared With Treatment With Oral Contraceptives in Polycystic Ovary Syndrome
Dorte Glintborg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome
Giovanni Targher et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)
Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation
Jane Skov et al.
THROMBOSIS RESEARCH (2014)
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity
H. Kahal et al.
CLINICAL ENDOCRINOLOGY (2013)
Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation
Florian Prueller et al.
ATHEROSCLEROSIS (2012)
Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis
Michelle L. Meyer et al.
HUMAN REPRODUCTION UPDATE (2012)
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
HUMAN REPRODUCTION UPDATE (2012)
Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue
Mattias Ekstrom et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome
Ertan Adali et al.
FERTILITY AND STERILITY (2010)
Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome
Asa Lindholm et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men
Torben Leo Nielsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity
R. Slopien et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism
D Glintborg et al.
CLINICAL ENDOCRINOLOGY (2005)
Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state
BO Yildiz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Share Paper
